Antiplatelet therapy in endovascular treatment for intracranial aneurysms, a multi center cohort study (APT-ANswer study)

Antiplatelet therapy in endovascular treatment for intracranial aneurysms, a multi center cohort study (APT-ANswer study) - Antiplatelet therapy in endovascular treatment for intracranial aneurysms, a multi center cohort study (APT-ANswer study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044122

Enrollment

500

Registered

2021-05-06

Start date

2021-05-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiplatelet therapy in neck-remodeling device-assiste d endovascular treatment for intracranial aneurysms, a multi center cohort study Antiplatelet therapy in neck-remodeling device-assiste d endovascular treatment for intracranial aneurysms, a multi center cohort study Antiplatelet therapy in neck-remodeling device-assiste d endovascular treatment for intracranial aneurysms, a multi center cohort study Antiplatelet therapy in neck-remodeling device-assiste d endovascular treatment for intra

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients with unruptured cerebral aneurysm over 20 years old 2) Patients who received stent-assisted neuroendovasc ular treatment for unruptured cerebral aneurysm from January 1, 2010 to December 31, 2020. 3) Patients who received periprocedural dual antiplate let therapy

Exclusion criteria

Exclusion criteria: (1) Patients who could not receive sufficient preoperati ve antiplatelet therapy due to emergency treatment for ruptured cerebral aneurysm, symptomatic cerebral an eurysm, etc. (2) In addition, patients who are judged to be inappro priate as targets by the judgment of the investigator.

Design outcomes

Primary

Measure	Time frame
Time from endovascular treatment to onset of thromb oembolic events related to target vessels, or death	—

Secondary

Measure	Time frame
1) hemorrhagic events equivalent to ISTH major bleed ing 2) hemorrhagic events which required intervention by a medical professional 3) asymptomatic ischemic lesion on MRI-DWI 4) Ischemic event other than cerebrovascular disease	—

Countries

Japan

Contacts

Public ContactHirofumi Matsubara

Gifu Univeristy Graduate School of Medicine Neurosurgery

neuro_s@gifu-u.ac.jp058-230-6271

Outcome results